# Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta‐analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-deucravacitinib-for-moderate-to-severe-plaque-psoriasis-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Cai-Xia Hu,Xiaomei Han,Yu Cui,Yan Zhang,Yi Cheng |
| Citations | 3 |
| DOI | 10.1111/srt.13855 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/srt.13855 |
| OpenAlex ID | https://openalex.org/W4401850333 |
| PMID | 39180322 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Xiaomei Han](https://scholariq.org/researchers/xiaomei-han/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.